BC Platforms launches BC Catalyst, first-to-market, AI-native analytics product that accelerates precision medicine
BC Catalyst transforms genomic and real-world data into fast, actionable insights to advance precision medicine at scale.

BC Unify is our AI-driven, end-to-end platform that integrates and transforms fragmented multi-modal data so that it’s ready to use across a wide range of healthcare and life sciences applications – serving as the critical foundation that powers our data, analytics and technology solutions.
As the the engine that fuels BC Platforms solutions, BC Unify ingests, enriches, and transforms diverse data types into a shared, harmonized structure that supports advanced analytics and healthcare research. Applying an agentic AI architecture informed by our deep domain expertise and decades of experience, BC Unify turns complex, multi-modal data into reliable, compliant, and research-ready information.

With its end-to-end data mastering capabilities, BC Unify manages the entire cycle of structured and unstructured healthcare data integration, eliminating fragmented approaches and inefficiencies at every step.
Automates the ingestion, harmonization, and transformation of structured and unstructured data from clinical and non-clinical sources to reduce silos and manual effort – efficient integration at scale.
Applies recognized standards such as OMOP, FHIR and SDTM to align datasets across systems, ensuring consistency, interoperability, and compliance for collaborative research and advanced analytics.
Uses propriety AI models to extract, structure and harmonize information, including unstructured text, with built-in machine learning, causal reasoning, and continuous quality checks to create complete, research-ready datasets.
Features an intuitive UI and built-in tools to process data quickly, maintain quality, and capture continuous feedback across the data lifecycle, accelerating data readiness so projects can start faster.
BC Unify quickly and intelligently accelerates data preparation, creating standardized, high-quality datasets that are ready for the advanced analytics and predictive modeling required for innovation and research.
Uses AI to extract and organize unstructured text, link diverse data sources, and create standardized knowledge models ready for comparison and discovery.
Combines curated datasets with trusted public knowledge sources via AI-generated models that add clinical context, improve interpretability, and enhance research analytics.
Automates continuous quality checks to detect gaps, correct inconsistencies, and ensure completeness throughout the data lifecycle.
Keeps partners aligned on study progress and quality through built-in query tools that allow real-time exploration and validation of datasets.
Automates data mapping, ingestion, and curation to reduce manual effort and accelerate time to research-ready data.
Uses machine learning and causal reasoning to enhance data accuracy, completeness, and interpretability over time.
Enables privacy-preserving simulations for predictive analytics and advanced data modelling that fill in or supplement gaps in data.
Draws on knowledge gained from decades of working with healthcare researchers worldwide to train data models.
BC Platforms meets the highest international standards for data protection, product quality, and ethical data governance. Our ISO-certified systems and compliance frameworks protect every stage of the data lifecycle, ensuring partners can innovate confidently and responsibly.
BC Catalyst transforms genomic and real-world data into fast, actionable insights to advance precision medicine at scale.
Zurich – 5th, February 2026 BC Platforms, a global leader in healthcare data, technology, and analytics today announced a strategic partnership with OmicsBank, a healthcare AI-ready data infrastructure company specializing in enabling access to large-scale, research-ready longitudinal and multi-modal real-world clinical and multi-omics datasets from emerging markets. The partnership expands BC Platforms’ global data partner
We partner with GeneVault to expand access to RWD from underrepresented populations across Asia, the Middle East, Africa, and Latin America.
Contact us to learn more about our solutions, see a live demo, or talk about how we can support your needs.